Greenleaf Health: Medpace : Partnership with Greenleaf Enhances Strategic Regulatory Affairs Capabilities

(marketscreener.com) Drug development continues to become more complex. Advances in gene and cell therapies, new service capabilities, big data and even changes to the way drug developers use statistical approaches are driving the growing complexity of designing and executing clinical trials. As drug developers utilize these cutting-edge approaches, it...https://www.marketscreener.com/quote/stock/MEDPACE-HOLDINGS-INC-30506552/news/Medpace-Partnership-with-Greenleaf-Enhances-Strategic-Regulatory-Affairs-Capabilities-32337468/?utm_medium=RSS&utm_content=20210202